Nifedipine: kinetics and dynamics after single oral doses

Area of Science:

• Pharmacology
• Clinical Pharmacology
• Cardiovascular Research

Background:

• Nifedipine is a widely used calcium channel blocker for cardiovascular conditions.
• Understanding its pharmacokinetics is crucial for optimizing therapeutic use.
• Assessing the impact of food on nifedipine absorption is important for patient guidance.

Purpose of the Study:

• To evaluate serum nifedipine concentrations and hemodynamic effects after oral administration.
• To determine the influence of food coingestion on nifedipine pharmacokinetics.
• To assess the appropriateness of standard dosing regimens for nifedipine.

Main Methods:

• Ten healthy volunteers received a single 40-mg oral dose of nifedipine.
• Serum nifedipine concentrations were measured over time.
• Hemodynamic parameters (blood pressure, heart rate) and echocardiographic data were recorded.
• Five subjects also ingested nifedipine with a standard breakfast to assess food effects.

Main Results:

• Peak serum nifedipine concentrations averaged 45 µg/L at 2.7 hours, with a mean elimination half-life of 5.9 hours.
• No significant differences in blood pressure, ventricular rate, or cardiac function were observed compared to placebo.
• Food delayed peak concentrations but did not alter the total area under the serum concentration curve (AUC).

Conclusions:

• The pharmacokinetic profile of nifedipine supports a three- or four-times-daily dosing schedule in clinical practice.
• Food coadministration does not affect the completeness of nifedipine absorption.
• Single oral doses of nifedipine do not appear to cause adverse hemodynamic effects in healthy individuals.